Beyond US: New shores, new bets Neha Aathavale Oct 12, 2026 The US remains a key market for Indian pharma. But changing conditions are pushing India to diversify its global footprint. The…
US tariffs leave Indian pharma unaffected, industry voices relief EP News Bureau Apr 3, 2025 Trump’s new tariffs impose 26% duty on India, while pharma remains exempt. Industry experts weigh in on the impact
